Q&A: Exploring the challenges behind oncology trials

Pauline Frank reflects on her talk at the 2023 CTO Europe conference and highlights some of the key issues in running oncology trials.

Related Posts

EMA CHMP issues positive opinion for AstraZeneca’s Soliris

Jun 27, 2023

FDA approves new administration routes for Xcopri 

Apr 13, 2024

Amgen in social media: theme innovation strategy

Mar 5, 2024